Related Experiment Video
Updated: May 25, 2026
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Stereotactic brainstem biopsy in a patient with coagulopathy of unclear etiology: case report
1Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany. christopher.beynon@med.uniheidelberg.de
Background:
Parenchymal hemorrhage is one of the most feared risks of stereotactic brain biopsies potentially resulting in neurological deficits or even a fatal outcome. Patients with disorders of the coagulation system are at particular risk, so identifying these is one of the main tasks prior to surgery. Some patients may have a bleeding tendency despite normal laboratory values of the hemostatic system.
Case Report:
We report the case of a patient with coagulopathy of unclear etiology undergoing a stereotactic brainstem biopsy.
Conclusion:
A medication scheme with tranexamic acid and desmopressin effectively decreased the patient's bleeding time in vivo and the procedure was carried out without complications.
